Pharmaxis granted FDA clearance to produce Aridol locally for US market

ASX-listed pharmaceutical company, Pharmaxis has today been granted FDA clearance to commence Sydney-based production of its asthma diagnostic medication, Aridol for the US. The approval follows hot-on-the-heels of the FDA’s recent inspection of the Sydney facility which manufactures Aridol for Australia, South Korea and Europe, and Bronchitol for Australia, Europe and Russia respectively. Following FDA…

Doctors encouraging middle-aged Aussie blokes to consider their prostate

Doctors are encouraging middle-aged Aussie blokes to have their prostate checked.Their call coincides with an article published in MJA Insight today (Monday, August 13), citing benign prostatic hyperplasia (BPH) – or a benign enlargement of the prostate –  can compromise a man’s quality of life, and his relationships with his partner and family.2   According…

Seqirus to release additional 700,000 adult flu vaccine doses to help boost “community immunity” against preventable infection

Seqirus announced the manufacture of another 500,000 doses of their adult influenza vaccine, Afluria Quad (inactivated quadrivalent influenza vaccine, split virion) today to help meet increasing consumer demand. Having fulfilled the government’s request to re-enter production, Seqirus is now ahead of the National Immunisation Program (NIP) schedule, with its first vaccine set for release this…

Mundipharma pioneering prostate cancer research in Australia

A Medical Oncologist from Chris O’Brien Lifehouse, Sydney has recently clinched a $60,000 2018 Mundipharma ANZUP Uro-Oncology Clinical Research Fellowship to support her research into prostate cancer. Dr Kate Mahon is the fifth recipient of the annual Clinical Research Fellowship awarded in partnership with the Australian and New Zealand Urogenital and Prostate Cancer Trials Group…

Low in magnesium? Talk to your doctor today.

Have you checked your magnesium levels lately? Stress, a poor diet and lack of vitamin D can strip the body of this vital mineral, together with excessive exercise and alcohol consumption, and Type 2 diabetes. Magnesium keeps your heart, muscles and blood pressure in check, maintains strong bones and regulates body temperature. A lack of…

Childhood depression and obesity link

The most recent childhood obesity data is cause for concern, with almost 28 per cent of Australian children recorded as either overweight or obese in 2014-15. A recent meta-analysis of more than 51,000 study participants has revealed a positive link between childhood and adolescent obesity and depression. Australian kids who are overweight and obese are…

Going “booze-free” for Dry July to help those affected by cancer

Are you willing to give up the booze this month? By celebrating ‘Dry July’, you’ll not only improve your general health and wellness, but also raise much needed funds for those affected by cancer, including patients and their carer’s. By abstaining from the bottle this month, you’ll be making a valuable contribution to wellness programs,…

Annual Biotechnology Industry Survey reveals strongest recorded business sentiment across sector since 2011

Almost four-in-five (77 per cent) AusBiotech Industry Survey respondents described the past 12 months as ‘excellent’ or ‘good’ – a five per cent increase on the previous year, and the strongest result recorded since the survey’s inception in 2011. Furthermore, almost 90 per cent of respondents said they expect their business to grow in 2018,…

Procedure guidance for medicines funded through Life Saving Drugs Program now available

VIVA! Communications congratulates the Department of Health for its publication of the long-awaited ‘Procedure guidance for medicines funded through the Government’s Life Savings Drugs Program (LSDP) – Version 1.0’. The procedural reform guidance outlines the consideration process for new life saving drugs, and medication reviews, among various other items. VIVA! Communications has a longstanding history…

New challenges for medicinal cannabis

The challenges medicinal cannabis is facing in Australia are coming thick and fast. Well, that’s what the Australian consumer and medical media would have you believe this week with a series of articles questioning the benefits of the plant when it comes to managing chronic pain and reducing opioid use. The coverage has come thanks…